Drug archive
Emtricitabine (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antiviral, systemic
Description
Emtricitabine (em-tri-SIT-uh-bean) is a type of medicine called an HIV (human immunodeficiency virus) nucleoside reverse transcriptase inhibitor (NRTI). Emtricitabine is always used with other anti-HIV medicines to treat people with HIV infection.
HIV infection destroys CD4 (T) cells, which are important to the immune system in your body. The immune system helps fight infection. After a large number of T cells are destroyed, acquired immune deficiency syndrome (AIDS) develops.
Emtricitabine helps to block HIV reverse transcriptase, a chemical in your body (enzyme) that is needed for HIV to multiply. Emtricitabine may lower the amount of HIV in your blood (viral load). Emtricitabine may also help to increase the number of T cells called CD4 cells. Lowering the amount of HIV in your blood lowers the chance of you having problems that happens when your immune system is weak.
Emtricitabine will not cure or prevent HIV infection or AIDS; however, it helps keep HIV from reproducing and appears to slow down the destruction of the immune system.
Emtricitabine will not keep you from spreading HIV to other people. People who receive this medicine may continue to have the problems usually related to AIDS or HIV disease
This medicine is available only with your doctor's prescription, in the following dosage form(s):
- Capsules (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Emtriva
† Not commercially available in Canada.